SEQIRUS UK LIMITED
Location
Founded
2015-05-29
Website
Risk Signals
39 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Offices of Holding Companies, Not Elsewhere Classified, Business Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SEQIRUS UK LIMITED
Live alerts from global media, monitored by Business Radar
2025-03-19 (pharmaphorum.com)
4th Circular & Self-Amplifying RNA Therapeutics Summit |
With CSL Seqirus and Arcturus Therapeutics successfully developing the first approved self-amplifying RNA vaccine, the field of next generation RNAs celebrates the potential of circular and self-amplifying RNAs to provide improved stability, durability, longevity and efficacy for treating a wide array of diseases.
Read more